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We report a familial case of the nephrogenic syndrome of inappropriate antidiuresis (NSIAD), including 30-year followup data on
two patients. The proband and one maternal uncle presented in their infancy with severe recurrent hyponatremia, and clinical
pictures consistent with the syndrome of inappropriate antidiuretic hormone (SIADH) in the absence of an elevated ADH
level. They were both conﬁrmed to be hemizygous for the R137C mutation on the V2R gene (AVPR2), the same locus of the
gain of function mutation demonstrated in the original reports of this condition. The proband’s mother was identiﬁed as an
asymptomatic carrier of this X-linked condition. Our case describes a favourable long-term outcome for NSIAD, in particular,
successful treatment with oral urea during the infancy period, and with self-regulated precautions on ﬂuid intake into adult life.
Copyright © 2009 Yoon Hi Cho et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.CaseDescription
1.1. Subject A: Index Case. An eight-week-old male infant
presented to a general hospital, after 5 hours of being
unsettledandvomiting,andaone-weekhistoryofcoughand
rhinorrhoea. Birthweight was 3660g at term gestation, and
he had previously been feeding well and gaining weight. His
parentswerenonconsanguineous,PortugueseandCaucasian
Australian background. There was a family history of two
maternal uncles who had a history of hyponatraemia of
uncertain aetiology. One had been diagnosed with SIADH
in his infancy and remained on a ﬂuid restriction into
adulthood. On examination, this infant had a viral rash
and mild respiratory distress and scattered wheeze. He
was clinically euvolaemic and not hyperpigmented. He had
normal external male genitalia. Chest X-ray did not show
focal pathology, but nasopharyngeal aspirate was positive
for Moraxella catarrhalis and he was treated with oral
amoxicillin. Blood tests revealed sodium 120mmol/L (refer-
ence range 135–145), potassium 4.8mmol/L (3.5–5.5), urea
1.9mmol/L (2.0–6.7), creatinine <20umol/L (20–45), glu-
cose 5.5mmol/L (3.5–5.5), and osmolality 255mM/kg (265–
295). Random adrenocorticotrophic hormone (ACTH) level
was normal 7.3pmol/L (2.0–10.0). Sodium chloride (NaCl)
supplementation 16mmol/kg/day was divided into his feeds,
and he was transferred to our centre.
On admission, serum Na remained low, 129mmol/L,
with osmolality 260mM/kg and paired urine Na <10
mmol/L and osmolality 506mM/kg. Antidiuretic hormone
(ADH) level <0.6pmol/L (0.1–7.0) and plasma renin activ-
ity (PRA) <32fM/s (1070–2930) were both suppressed
below the reference range. Aldosterone was 440pmol/L
(80–1040). Short Synacthen test demonstrated a normal
cortisol response, rising from baseline 130nmol/L to peak
1393nmol/L at 60 minutes, and normal stimulated 17-
hydroxyprogesterone to cortisol ratios. Baseline ACTH level
was conﬁrmed to be normal. Renal ultrasound visualised
normal kidneys and bladder, with both testes present
within the scrotum. The above investigations therefore
excluded adrenal hormonal and renal structural abnor-
malities. Sodium improved to 131mmol/L, and he was
discharged home on oral salt supplementation.
He represented with hyponatraemia, vomiting, and feed
refusal, leading to two additional hospital admissions within
the next two weeks. On both occasions, he appeared well and
euvolemic. Despite low Na 125mmol/L and serum osmo-
lality 255mM/L, he now demonstrated an inappropriately
high urine sodium 104mmol/L and osmolality 335mM/L.2 International Journal of Pediatric Endocrinology
Table 1: Monitoring urea therapy.
Age (months) 3 (pre-urea
therapy) 4 6 (intercur-
rent illness) 10 18 19 21 33
Serum Na
(135–145
mmol/L)
124 139 118 136 140 137 138 139
Serum urea
(2.0–6.7
mmol/L)
1.8 10.2 12.6 9.9 9.4 6.1 5.1 3.1
ADH (0.1–
7.0pmol/L) 0.6 — — — — — — 1.2
Urea dose
1.5g/kg/day,
6d i v i d e d
doses
2g/kg/day, 4
divided doses
2g/kg/day, 4
divided doses
1.9g/kg/day, 4
divided doses
1.2g/kg/day,
Weaning doses Ceased Nil Nil
Fluid
restriction 70mL/kg/day 50mL/kg/day 50mL/kg/day 65mL/kg/day
(650mL/day)
80mL/kg/day
(1000mL/day)
80mL/kg/day
(1000mL/day)
90mL/kg/day
(1200mL/day)
75mL/kg/day
(1200mL/day),
increased to
94mL/kg/day
(1500mL/day)
Repeat ADH level was detectable but low (0.6pmol/L);
aldosterone was 497pmol/L and PRA remained suppressed.
Sodiumlevelrespondedtoaﬂuidrestrictionof60mL/kg/day
and intravenous 0.9% saline infusion, rising to near-
normal levels after 48 hours. When ﬂuids were liberalised
to oral feeds, serum sodium declined from 138mmol/L
to 124mmol/L, even whilst on NaCl supplementation of
5mmol/kg/day. Thyroid function tests were normal. Chest
X-ray now showed subsegmental collapse in the right upper
zone and consolidation in the right middle zone. Throat
suction swab grew Staphylococcus aureus, which was treated
withatwo-weekcourseoforalﬂucloxcillin.Newbornscreen-
ing, extended genetic analysis for common cystic ﬁbrosis
transmembrane conductance regulator (CFTR) mutations,
and a sweat test excluded cystic ﬁbrosis as a cause for
salt loss and respiratory symptoms. Abdominal ultrasound
and surgical consultations were sought to exclude pyloric
stenosis. Magnetic resonance imaging of the brain was
normal.
This clinical picture of SIADH despite low to normal
ADHlevelsraisedthepossibilityofareceptororpostreceptor
defect. A provisional diagnosis of the recently described
“nephrogenic syndrome of inappropriate antidiuresis” was
made and this was later conﬁrmed by genetic studies (see
below). He was commenced on oral urea at 1.5g/kg/day
in 6 divided doses and maintained on a ﬂuid restriction
of 70ml/kg/day. Feeds were concentrated to provide more
calories. The dose of urea was gradually increased and well
tolerated at a target dose of 2g/kg/day, without any evidence
of dehydration. Sodium in midnormal range and slightly
elevated urea levels were indicators of compliance (Table 1).
By 6 months of age, the infant was on a predominantly solid
diet and has since remained on a modest ﬂuid restriction.
Urea was able to be weaned and ceased by 19 months of age.
He demonstrated appropriate developmental progress and
growth.
1.2. Subject B: Maternal Uncle 1 of Index Case. Medical
records of the maternal uncle of Patient A were reviewed.
Subject B had presented to our hospital 29 years earlier
with a generalized tonic clonic seizure at age of 22 months.
There was a 3-day history of ataxia and lack of interest in
feeding preceding this event. He was born at term and had
an uneventful neonatal history. He was noted by his mother
to be usually reluctant to drink, and on the night before
the presentation, he was given additional ﬂuids to try to
settle him. There was evidence of mild delay in gross motor
development, crawling at 13 months, and walking unaided
at 17 months. He was able to speak 20 words by 19 months
of age. On examination, he was afebrile and hypertensive
with BP 130/90 but otherwise had normal examination.
Weight was 10kg (3rd percentile) and head circumference
was 47.5cm (50th percentile).
Serumsodiumonadmissionwas124mmol/Lwithblood
glucose level 2.2mmol/L. Other electrolytes and full blood
counts were normal. Serum osmolality was 265mmol/kg,
with urine osmolality inappropriately concentrated at
950mmol/kg. He sustained another convulsion during the
hospital admission. The diagnosis at the time of discharge
was seizures of unknown aetiology, with concurrent SIADH.
He was maintained on oral phenobarbitone.
Followup blood tests two days later showed severe
hyponatraemia of 112mmol/L. He was slightly irritable and
ataxic, but otherwise displayed normal examination. Fluid
restriction was commenced at 500mL/day. Extensive inves-
tigations, including a brain scan, were unremarkable. Syn-
acthen stimulation test showed a normal cortisol response. A
water-loadingtestshowedserumsodiumfallingto129mmol
at 6 hours, with osmolality of 287mmol/kg, and high urine
sodium 199mmol/L and osmolality 1092mmol/kg.
The most likely diagnosis was considered to be SIADH,
but serum ADH estimation was found to be low at
1.43pg/mL (mean adult level 6.5pg/mL). This was at a timeInternational Journal of Pediatric Endocrinology 3
(1977)whenthisassayhadjustbecomeavailableinAustralia,
so there were concerns about accuracy. At age of 31 years,
Patient B is working as an accountant and had remained
generally well throughout his childhood with spontaneous
limitation of ﬂuid intake. He knew that he needed to restrict
free water intake in order to maintain his sense of well
being but was not aware of his underlying diagnosis. On one
notable occasion he had taken an extended ﬂight and drank
extra water and no alcohol as suggested by the ﬂight crew.
At his destination he was described to be in a confused state
which resolved after several hours, but of which he retained
no memory.
1.3. Subject C. Patient C was the other maternal uncle,
currently a manager in the automotive industry. He and his
family were unaware of any problems in childhood, although
as an adult he had had several episodes of being unwell and
was found to have a mildly low sodium at the time, although
had not been further investigated. He was aware that he had
a low thirst and low ﬂuid intake compared to others.
1.4. Family Study. Consent was obtained from the family
members of the index case for genetic testing of the
mutation described by the original case report by Feldman
et al. Samples were sent to Quest Diagnostics (R. Fenwick,
Nichols Institute, CA, USA) for DNA analysis. After PCR
ampliﬁcation of the AVPR2 gene, mutations were detected
by DNA sequence analysis of all protein coding regions of
the gene plus ﬂanking sequences [1]. The index case (Patient
A) was found to be positive for the R137C mutation.
His mother was asymptomatic with normal serum
sodium 145mmol/L. She was found to be a heterozygote
carrier for the R137C mutation.
Maternal uncle 1 (subject B) had current baseline hyp-
onatraemia without symptoms, with Na 131mmol/L, serum
osmolality 264mM/kg, urine osmolality 851mM/kg, and
ADH <0.6pmol/L. He was found to be positive for the
R137C mutation.
Maternal uncle 2 (subject C) had baseline Na 133
mmol/L, serum osmolality 279mM/kg, and urine osmolality
946mM/kg. ADH was 1.36pg/mL (<1pg/mL), considered
high for the serum osmolality. He was also found to be
positive for the R137C mutation.
Maternalauntwasasymptomaticand6monthspregnant
at the time of testing. Laboratory studies were normal, and
she was not a carrier of the mutation.
2. LiteratureReview andDiscussion
In 2005, Feldman et al. [1] described a clinical condition
resulting from a gain of function of the vasopressin receptor
(V2R gene), which was named nephrogenic syndrome of
inappropriate antidiuresis. This can be conceptualised as
the opposite phenomena to nephrogenic diabetes insipidus,
which results from a loss of function of the vasopressin
receptor. In the original article, two unrelated male infants
were found to have the clinical picture of SIADH in the
absence of an elevated ADH. In patient 1, the arginine
on codon 137 was substituted with cysteine (R137C), and
his mother was heterozygous for the R137C mutation,
suggestinganX-linkedinheritance.Inpatient2,argininewas
substituted with leucine (R137L), with no mutation found
in his mother, likely as a result of spontaneous mutation.
Functional analysis conﬁrmed constitutive activation of this
receptor.
Over 200 diﬀerent mutations on the V2R gene have been
found to cause nephrogenic diabetes insipidis [2]. It has
therefore been postulated that a genetic heterogeneity may
exist in NSIAD. To date, however, the R137C has been the
mutation predominantly implicated, apart from one case of
an R137L mutation. There may also be other parts of the
signalling pathway which are yet not clearly understood.
Mutations in the V2R gene may not explain all cases
of NSIAD. In 2001, Tanaka et al. described a three-
generation family to have an “SIADH-like condition” with
undetectable ADH levels [3]. The 12-month-old proband
presented with persisting hyponatraemia following a febrile
seizure. The 32-year-old mother and 59-year-old maternal
grandmother self-restricted ﬂuid intake and had low to low
normal baseline serum sodium. A water-loading test on
all three subjects showed impaired water excretion. Urine
aquaporin-2 (AQP2) concentration, which is a marker of
AVP dependent AQP2 levels, was normal. The plasma AVP
was undetectable in the proband and mother (grandmother
refused sampling). A “gain of function” mutation involving
the AVP receptor or aquaporin channel was considered but
DNA sequencing for both AVPR2 and AQP2 was found to
be normal. Another interesting aspect of this case series is
that all three aﬀected members were females. Although X-
linked conditions can be partially expressed in a female,
or fully expressed in the presence of Lyonisation or 45XO,
this familial pattern can also be consistent with autosomal
dominant and suggests that other genetic causes or another
level of constitutive activation may be involved [3].
Another report identiﬁed the activating missense muta-
tion on R137C in three hemizygous males and fourheterozy-
gous females of a large family pedigree [4]. It highlighted
several important aspects of this condition: presence in
adulthood and presence of symptoms in both males and
females. All except one female, subsequently found to have
skewed X inactivation, had spontaneous hyponatraemia or
an abnormal water-loading test.
The current reports of NSIAD to date are primarily
infants who have had recurrent presentations with hypona-
traemia and often seizures. The diagnosis may be elusive and
often requires extensive investigations to exclude underlying
central or pulmonary pathology. There may be concurrent
clinical factors contributing to the hyponatraemia, such as
the intercurrent respiratory illness in our patient. Precip-
itants may include excessive bottle feeding and, in adults,
prolonged exercise [5] or hot days with extra ﬂuid intake,
alcohol binges, and overriding one’s own protective thirst
mechanisms.
The condition can also present in adulthood and should
be suspected in a patient with a clinical diagnosis of SIADH,
unresponsive to usual medications used in chronic SIADH,
including the new V2R antagonist tolvaptan [4].4 International Journal of Pediatric Endocrinology
Developmentally, the neonate and infant seem to be at
high risk for hyponatremia with NSIAD. This is a time when
diet consists predominantly of liquid, with low solute load,
and feeding may be more dependent on issues other than
thirst. Indeed, it is not well understood how and when the
thirst mechanism develops, presumably sometimes in this
ﬁrst year of life. Nonetheless, as awareness of thirst evolves
over time, the risk for severe hyponatremia from excessive
free water seems to drop over time.
The variability in clinical severity and age of onset has
been proposed to be due to the variable genetic expressivity
of the disease [4]. The variability may also relate to other
downstream factors, such as aquaporin expression. It may
also relate to drinking behaviour and how aggressive parents
arewithearlyfeeding practices.Ourcasehighlights that even
those who present in infancy can lead a relatively normal
childhood and reach adult life with minimal symptomatic
episodes. It supports previous reports that aﬀected indi-
viduals can often self-regulate ﬂuid intake. It also raises
the question as to how common this condition might be,
since there could be a larger number of genetically aﬀected
individualswhoremainasymptomatic,orhaveneverhadfull
evaluation.
Regardingtreatment,pharmaceuticalgradeureawaseasy
to obtain and relatively well tolerated by our patient, despite
the unpleasant taste as observed by the mother and others.
Eﬀective treatment with oral urea has been described in two
other cases of NSIAD, including the original report, and
reported in the management of other children with chronic
SIADH [6].Subject A was treated with oral urea at dose of
2g/kg/day in 4 divided doses and modest ﬂuid restriction
withregularelectrolytemonitoring.Hemaintainedgenerally
stable electrolytes, apart from one episode of hyponatremia
associated with an intercurrent viral illness in which he did
not take his urea well but took extra ﬂuids. In the ﬁrst 6
months of life, urea levels on treatment were maintained in
high normal range. After 10 months of age, dose required
no adjustment increase with age, and from 18 months,
gradual weaning of dose was undertaken with continuation
of modest ﬂuid restriction. Urea treatment was ceased
at 19 months of age (16-month treatment) and modest
ﬂuid restriction continues at 1500mL per day. In another
reported case, urea was ceased at age of 10 months (9-month
treatmentduration)[7]Wepostulatethatthedecreasedneed
for urea is most likely commensurate with the development
of a reliable thirst mechanism.
Based on current understanding, indications for muta-
tion analysis would be idiopathic SIADH with low or
inappropriately normal ADH (5%–10% SIADH) [8], family
history of hyponatraemia, or SIADH (as was the clue
in our case) and perhaps as a part of the investigation
panel for poorly deﬁned entities such as exercise-induced
hyponatraemia. Once detected, family members can be
screened to identify carriers or mildly aﬀected individuals
and given advice about the risk of developing symptomatic
hyponatremia in the presence of water loading. We were able
to advise a maternal family member who was pregnant at the
time of mutation studies that she was not a carrier of this
mutation and that her child would not be aﬀected. Further
elucidation of the genetic variation and delineation of intra-
cellular signalling pathways may reveal wider spectrum of
manifestation in this interesting clinical entity.
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